Page last updated: 2024-08-21

oxymetholone and Angiogenesis, Pathologic

oxymetholone has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Han, DH; Hong, DS; Ji, YS; Kim, CK; Kim, HJ; Kim, HK; Kim, KH; Kim, SH; Lee, KT; Lee, MS; Min, CW; Park, SK; Won, JH; Yun, J	1

Other Studies

1 other study(ies) available for oxymetholone and Angiogenesis, Pathologic

Article	Year
Biomarkers of angiogenesis as prognostic factors in myelodysplastic syndrome patients treated with hypomethylating agents. Leukemia research, 2016, Volume: 50 Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Marrow Examination; Humans; Immunosuppressive Agents; Microvessels; Middle Aged; Myelodysplastic Syndromes; Neovascularization, Pathologic; Oxymetholone; Prognosis; Pyridoxine; Retrospective Studies; Survival Rate; Vascular Endothelial Growth Factor A; Young Adult	2016

Article

Year

Biomarkers of angiogenesis as prognostic factors in myelodysplastic syndrome patients treated with hypomethylating agents.

Leukemia research, 2016, Volume: 50

Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Marrow Examination; Humans; Immunosuppressive Agents; Microvessels; Middle Aged; Myelodysplastic Syndromes; Neovascularization, Pathologic; Oxymetholone; Prognosis; Pyridoxine; Retrospective Studies; Survival Rate; Vascular Endothelial Growth Factor A; Young Adult

2016